Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.2489
-0.0261 (-9.49%)
Apr 20, 2026, 11:20 AM EDT - Market open
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $2.75 million as of April 20, 2026. Its market cap has decreased by -85.91% in one year.
Market Cap
2.75M
Enterprise Value
1.57K
1-Year Change
-85.91%
Ranking
Category
Stock Price
$0.25
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $2.75M, a decrease of -99.00%. That is a compound annual growth rate of -64.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 3.04M | -64.52% |
| Dec 31, 2025 | 8.56M | -61.46% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
| Nov 1, 2021 | 273.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 3.68M |
| Silexion Therapeutics | 3.56M |
| Azitra | 3.48M |
| Enveric Biosciences | 3.44M |
| GeoVax Labs | 3.26M |
| Matinas BioPharma Holdings | 3.20M |
| Oragenics | 3.10M |
| Decoy Therapeutics | 3.09M |